gene_id,uniprot_accession.x,gene_name.x,Entry.Name.x,Protein.names.x,Gene.Names.x,Gene.Ontology.biological.process.x,Gene.Ontology.IDs.x,PSC.56,PSC.52,PSC.54,PSC.61,PSC.64,PSC.73,PSC.76,PSC.81,PSC.59,PSC.57,PSC.69,PSC.67,PSC.71,PSC.75,PSC.78,PSC.83,PSC.0228,PSC.0187,PSC.0188,PSC.0174,PSC.0190,PSC.0231,PSC.0230,PSC.0219,PSC.0177,PSC.0186,PSC.0209,PSC.0203
g19475,Q9H3F6,BACD3_HUMAN,BACD3_HUMAN,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),KCTD10 ULR061 MSTP028,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260,499,525,567,480,838,747,407,516,951,1058,669,1430,1458,2823,628,4910,1558,1176,670,1012,1250,622,381,302,415,293,310,332
g14478,P0C2W1,FBSP1_HUMAN,FBSP1_HUMAN,F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45),FBXO45 FBX45,anterior commissure morphogenesis [GO:0021960]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; DNA damage response [GO:0006974]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001764; GO:0005576; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0070936; GO:0098978; GO:0099523; GO:0099524; GO:1990756; GO:2000300,138,167,170,307,296,169,165,216,68,35,5,51,47,4,64,0,21,17,11,21,10,15,102,125,144,120,137,100
g9753,Q6I6G8,HECW2_MOUSE,HECW2_MOUSE,"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)",Hecw2 Kiaa1301 Nedl2,protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686,1082,1514,1359,1571,2019,1624,1681,2130,2083,1970,1002,2405,1278,695,855,1925,1688,1093,1144,938,1463,1091,1776,752,697,1428,591,902
g13596,Q4G0X4,KCD21_HUMAN,KCD21_HUMAN,BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21),KCTD21,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602,6,0,1,5,9,8,19,7,0,8,11,19,23,8,8,157,32,114,106,5,0,63,2,9,4,0,0,7
g17328,Q9HAU4,SMUF2_HUMAN,SMUF2_HUMAN,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),SMURF2,"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0017015; GO:0030512; GO:0030514; GO:0042802; GO:0043161; GO:0045121; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165,141,108,130,116,121,148,156,210,182,238,66,314,119,124,157,505,220,159,155,155,224,219,125,84,111,97,52,168
g4809,Q5ND34,WDR81_MOUSE,WDR81_MOUSE,WD repeat-containing protein 81,Wdr81,aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010008; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0045022; GO:0050821; GO:0070530; GO:0141039,557,750,810,636,604,501,828,1096,159,62,182,422,190,13,140,84,165,158,249,90,40,106,663,312,235,475,296,276
g13964,P49407,ARRB1_HUMAN,ARRB1_HUMAN,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ARR1,G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0007601; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:1990763,2153,3919,4520,3409,2708,3902,4404,3620,536,374,384,1346,929,120,298,463,572,784,467,246,206,316,2959,2135,1251,2140,1019,1643
g14365,B4F6W9,TRIPC_XENTR,TRIPC_XENTR,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),trip12,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0008270; GO:0033696; GO:0045995; GO:0061630; GO:0140861,3365,2902,2940,2112,3120,2313,3117,3790,3151,3668,1783,5671,3591,933,1483,4179,3293,2798,2152,2118,2994,2305,3089,1657,1239,2736,1159,1990
g1423,Q15386,UBE3C_HUMAN,UBE3C_HUMAN,Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2) (HectH2) (RTA-associated ubiquitin ligase) (RAUL),UBE3C KIAA0010 KIAA10,protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000502; GO:0006511; GO:0035519; GO:0061630; GO:0070936,610,463,578,455,474,419,516,557,604,1017,232,895,707,315,166,602,1038,409,480,453,257,369,310,314,243,308,313,229
g11349,Q9P2G1,AKIB1_HUMAN,AKIB1_HUMAN,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),ANKIB1 KIAA1386,protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0061630,435,378,406,259,371,293,381,497,299,331,367,1029,464,233,235,772,567,1232,468,261,362,394,328,236,122,188,234,200
g3038,Q6J1I7,RN166_RAT,RN166_RAT,E3 ubiquitin-protein ligase RNF166 (EC 2.3.2.27) (RING finger protein 166) (RING-type E3 ubiquitin transferase RNF166),Rnf166,autophagy [GO:0006914]; innate immune response [GO:0045087]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0005737; GO:0006511; GO:0006914; GO:0045087; GO:0046872; GO:0061630,185,281,387,231,310,409,324,472,50,46,51,85,90,7,57,34,34,46,18,32,0,37,155,94,65,140,119,105
g2851,Q9JLV2,TP4AP_MOUSE,TP4AP_MOUSE,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),Trpc4ap Trrp4ap,hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0080008; GO:0140627; GO:1990756,745,661,1095,773,977,1031,879,911,857,1138,415,1215,827,834,388,1894,973,682,557,1020,911,627,618,437,477,457,379,437
g15362,O43242,PSMD3_HUMAN,PSMD3_HUMAN,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),PSMD3,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813,1970,1962,1786,1554,2273,1613,1706,2240,2523,3123,1981,3302,3361,1265,1541,2607,2367,1293,1359,1304,1413,1341,1389,717,1011,885,1244,761
g15763,P53804,TTC3_HUMAN,TTC3_HUMAN,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3),TTC3 DCRR1 RNF105 TPRD,protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936,863,885,1314,752,1839,1397,827,1174,922,1084,1555,1923,2128,963,634,2537,1968,2431,1777,3466,1639,1106,912,624,772,952,404,438
g15764,P53804,TTC3_HUMAN,TTC3_HUMAN,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3),TTC3 DCRR1 RNF105 TPRD,protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936,4408,4010,5264,4117,8552,7354,4226,5937,4316,6081,4329,10762,9442,3473,4028,12812,10710,12188,9872,12283,8683,6790,5258,3339,3215,5187,3889,2611
g15765,O88196,TTC3_MOUSE,TTC3_MOUSE,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Mtprd),Ttc3 Kiaa4119,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0030517; GO:0045665; GO:0046872; GO:0070936,391,356,669,414,1462,457,488,341,285,831,1003,693,1122,1022,491,2228,617,868,699,1825,478,618,370,355,298,258,214,121
g21739,P25867,UBCD1_DROME,UBCD1_DROME,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),eff UbcD1 CG7425,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,2309,2982,3313,2570,5661,4452,2750,3693,6604,9558,3468,7213,5935,3998,2336,8893,5037,2304,3290,4889,5468,3889,2498,2095,2306,1490,1053,1597
g11649,Q9ES00,UBE4B_MOUSE,UBE4B_MOUSE,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),Ube4b Ufd2 Ufd2a,ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051117; GO:0051865; GO:0061630,2438,1243,1297,833,1012,1106,1244,1418,1593,1228,764,2653,3863,1349,1363,5148,2198,1249,1323,1492,1523,922,2253,595,612,699,530,677
g11648,Q9BXM7,PINK1_HUMAN,PINK1_HUMAN,"Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1)",PINK1,"activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; dopamine secretion [GO:0014046]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cristae formation [GO:1903852]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000287; GO:0000422; GO:0000423; GO:0000785; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0014046; GO:0016020; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030097; GO:0030424; GO:0030426; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0042981; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:0106310; GO:1900407; GO:1901525; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903214; GO:1903298; GO:1903377; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243,7027,10115,11223,10519,21693,17730,13574,13614,25062,30810,34671,26158,33844,4438,10081,17727,15901,20519,11256,4941,9416,12327,7133,4719,6691,7245,13877,6905
g12645,Q9P0J7,KCMF1_HUMAN,KCMF1_HUMAN,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1),KCMF1 FIGC ZZZ1,negative regulation of HRI-mediated signaling [GO:0141191]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]; synaptic signaling [GO:0099536]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0008270; GO:0043161; GO:0045202; GO:0061630; GO:0070534; GO:0070936; GO:0099536; GO:0141191; GO:1904813,655,679,564,398,656,565,564,839,712,751,299,965,887,224,589,550,436,326,306,322,283,352,498,379,319,312,254,338
g11157,Q8BM54,MYLIP_MOUSE,MYLIP_MOUSE,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain-interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Mylip,cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0046872; GO:0061630; GO:0071404,247,311,423,288,217,304,398,386,59,45,44,206,113,8,145,47,85,105,108,82,20,45,257,156,97,362,197,166
g16729,Q9VBP9,NPL4_DROME,NPL4_DROME,Nuclear protein localization protein 4 homolog,Npl4 CG4673,cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586,199,258,356,148,347,271,319,254,467,520,180,428,374,203,318,550,431,210,141,227,230,172,199,135,146,101,131,145
g16728,P60670,NPL4_MOUSE,NPL4_MOUSE,Nuclear protein localization protein 4 homolog (Protein NPL4),Nploc4 Kiaa1499 Npl4,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117,227,226,241,104,280,153,231,229,271,445,121,311,299,128,196,402,215,128,115,262,141,143,125,76,89,60,52,50
g19294,Q96AB6,NTAN1_HUMAN,NTAN1_HUMAN,Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase),NTAN1,adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418,644,851,994,695,1127,995,681,1048,175,247,100,175,241,91,192,241,151,116,122,393,47,51,635,749,443,450,380,211
g3351,Q9R049,AMFR_MOUSE,AMFR_MOUSE,E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING-type E3 ubiquitin transferase AMFR),Amfr,endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical NF-kappaB signal transduction [GO:0038061]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000151; GO:0000166; GO:0000209; GO:0004842; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006511; GO:0007611; GO:0016055; GO:0030425; GO:0030426; GO:0030674; GO:0030968; GO:0032991; GO:0034450; GO:0036503; GO:0036513; GO:0038023; GO:0038061; GO:0042802; GO:0043025; GO:0043130; GO:0044314; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1990381; GO:2000638,1004,1309,1503,1345,1367,1509,1509,1559,1209,1449,907,1554,1508,553,880,1253,1091,973,808,774,742,981,942,525,725,733,612,688
g21569,Q6NW85,ARI1L_DANRE,ARI1L_DANRE,E3 ubiquitin-protein ligase arih1l (EC 2.3.2.31),arih1l zgc:85905,protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630,234,429,440,222,230,261,338,507,1647,2262,557,842,891,1980,286,6294,1445,2102,3158,1032,2437,991,283,157,31,144,221,121
g8682,Q9CPX9,APC11_MOUSE,APC11_MOUSE,Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11),Anapc11,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005654; GO:0005680; GO:0005730; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031145; GO:0034450; GO:0045842; GO:0051301; GO:0061630; GO:0070936; GO:0070979; GO:0097602; GO:0141198,328,382,355,459,556,452,368,496,475,500,671,322,902,342,671,442,351,292,293,246,243,114,172,220,248,145,118,181
g12673,Q3ULA2,FBW1A_MOUSE,FBW1A_MOUSE,F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit),Btrc Fbw1 Fbxw1 Fwd1 Kiaa4123,branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-templated transcription [GO:0045892]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1990756; GO:1990757,899,650,615,486,700,934,768,916,1580,1593,768,2666,2020,729,601,3096,1297,1731,1745,1625,1963,1889,695,407,489,513,209,466
g11249,Q9H0E2,TOLIP_HUMAN,TOLIP_HUMAN,Toll-interacting protein,TOLLIP,autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005150; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019897; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0060090; GO:0070062; GO:0070498,910,1501,2060,1640,2246,2163,1515,1880,2054,4017,1702,2778,2445,1749,896,4606,2167,1808,1514,2057,1977,1756,928,749,994,803,677,637
g10192,F6P3G4,PS11A_DANRE,PS11A_DANRE,26S proteasome non-ATPase regulatory subunit 11A (26S proteasome regulatory subunit RPN6-A),psmd11a,proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0008541; GO:0022624; GO:0043248; GO:0048863,4088,2888,2808,1728,4382,3465,2452,3191,2876,3985,2650,3744,4837,1322,2476,1984,1875,1202,1395,1555,989,916,1474,1009,1289,1160,1128,857
g17979,Q8BW70,UBP38_MOUSE,UBP38_MOUSE,Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38),Usp38,negative regulation of innate immune response [GO:0045824]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0032435; GO:0045824; GO:0140311,526,539,680,488,547,663,619,779,801,915,212,637,776,428,453,990,960,402,464,521,940,774,732,461,562,531,596,483
g19281,Q5SPX3,RN215_MOUSE,RN215_MOUSE,RING finger protein 215,Rnf215,ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006511; GO:0016020; GO:0046872; GO:0061630,224,242,145,96,128,187,257,205,16,8,0,87,49,0,31,18,11,18,15,25,0,0,87,62,22,119,106,49
g10576,Q5E964,PSD13_BOVIN,PSD13_BOVIN,26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5),PSMD13,ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0008541; GO:0022624,1818,1305,1211,835,1877,1513,1023,1133,1437,1673,1139,1722,2073,502,1631,1085,1237,548,888,709,446,490,665,511,658,481,536,255
g14231,Q9UBF6,RBX2_HUMAN,RBX2_HUMAN,RING-box protein 2 (Rbx2) (EC 2.3.2.27) (EC 2.3.2.32) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein),RNF7 RBX2 ROC2 SAG,endoplasmic reticulum unfolded protein response [GO:0030968]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0030968; GO:0031466; GO:0038026; GO:0043161; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0070979; GO:0097602; GO:2001222,1562,1215,1563,1333,1646,1691,950,1311,2335,5998,1705,2473,5534,2193,1011,4159,2152,1228,1274,1382,2750,2379,777,617,956,549,832,591
g6193,O08759,UBE3A_MOUSE,UBE3A_MOUSE,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP),Ube3a,androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008021; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0043161; GO:0045944; GO:0046872; GO:0048167; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:1990416; GO:2000058,1325,1076,1012,597,725,772,1068,1077,864,711,1101,1446,1815,639,1071,2032,1049,939,559,641,868,643,684,409,402,560,494,311
g11424,Q9Y5A7,NUB1_HUMAN,NUB1_HUMAN,NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18),NUB1 NYREN18,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:2000058,385,337,465,254,306,255,303,405,328,336,165,402,300,442,177,1138,275,171,233,261,363,109,166,130,105,169,232,127
g11856,Q923V4,FBX6_RAT,FBX6_RAT,F-box only protein 6 (F-box only protein 6b) (F-box protein that recognizes sugar chains 2) (F-box/G-domain protein 2),Fbxo6 Fbg2 Fbs2 Fbxo6b,DNA repair [GO:0006281]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005737; GO:0006281; GO:0006511; GO:0006516; GO:0006986; GO:0016567; GO:0019005; GO:0030246; GO:0031146; GO:0036503; GO:0044322; GO:0061630,1169,1004,834,704,986,950,1052,923,383,240,289,525,389,173,638,190,94,61,82,159,108,96,733,490,609,564,445,410
g1093,Q3T0J1,FBX4_BOVIN,FBX4_BOVIN,F-box only protein 4,FBXO4,positive regulation of protein ubiquitination [GO:0031398]; protein polyubiquitination [GO:0000209]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0000723; GO:0005737; GO:0006511; GO:0019005; GO:0031146; GO:0031398,0,0,3,0,17,8,32,0,324,609,67,179,145,654,306,207,139,101,705,18,61,320,0,21,0,0,0,3
g19466,Q92890,UFD1_HUMAN,UFD1_HUMAN,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),UFD1 UFD1L,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218,912,1218,1074,367,628,808,676,1165,872,1235,398,903,1343,357,1764,677,771,232,367,435,358,388,605,382,167,290,117,229
g6469,O95628,CNOT4_HUMAN,CNOT4_HUMAN,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),CNOT4 NOT4,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865,1122,1683,1223,1000,1115,1429,2015,2507,1861,2629,838,2940,1869,794,748,3343,3034,1867,1879,1339,2688,2375,1655,778,505,1257,545,1159
g21198,Q29504,UBA1_RABIT,UBA1_RABIT,Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1),UBA1 UBE1,DNA damage response [GO:0006974]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974,2448,3153,4642,3158,5002,3657,3765,4354,6452,8318,3605,8782,7552,2439,3127,8389,7978,6432,4564,5312,4418,4661,3487,2130,2894,2304,2156,2370
g16116,P18101,RL40_DROME,RL40_DROME,Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40)],RpL40 Ubi-f UBI-F52 CG2960,cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; translation [GO:0006412]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0006511; GO:0016567; GO:0019941; GO:0022625; GO:0022627; GO:0031386; GO:0031625; GO:0036211,14294,12254,10238,6651,11006,11035,8989,12499,11774,9015,11172,12219,12090,4344,18917,8973,5130,6295,4521,5347,4089,4941,4890,3484,3461,4153,1599,4433
g14809,Q5RKH6,OS9_RAT,OS9_RAT,Protein OS-9,Os9,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0002020; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503; GO:1904153,955,1193,1200,860,1104,902,1269,1318,311,232,220,570,397,38,767,140,150,128,238,162,37,285,705,652,699,600,671,473
g22410,Q9NV58,RN19A_HUMAN,RN19A_HUMAN,E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38),RNF19A RNF19,"microtubule cytoskeleton organization [GO:0000226]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016020; GO:0031624; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576,944,588,590,582,633,774,752,676,526,747,299,1187,779,381,368,826,935,732,693,258,532,1115,561,385,360,460,305,484
g2814,Q6TEM9,MYLIA_DANRE,MYLIA_DANRE,E3 ubiquitin-protein ligase MYLIP-A (EC 2.3.2.27) (Myosin regulatory light chain-interacting protein A) (MIR-A) (RING-type E3 ubiquitin transferase MYLIP-A),mylipa mir mylip si:ch211-266j17.1,gastrulation [GO:0007369]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0006511; GO:0007369; GO:0016567; GO:0030178; GO:0046872,2120,3143,2988,1915,2969,2429,2296,2378,3391,3029,1132,1981,1681,3821,1302,7335,2455,1555,2387,8431,3262,2015,2256,1696,2302,1376,2276,1950
g15594,P22682,CBL_MOUSE,CBL_MOUSE,E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL),Cbl,bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; DNA damage response [GO:0006974]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0001784; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006468; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0008584; GO:0010332; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019901; GO:0030424; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045453; GO:0045471; GO:0046875; GO:0048260; GO:0048471; GO:0051865; GO:0051897; GO:0061630; GO:0070086; GO:0071456; GO:1990090; GO:1990782; GO:2000583,953,1571,1743,1296,2184,1493,1750,2078,1941,3463,740,2550,1396,989,811,3072,2928,1893,2049,2674,2898,2402,2607,1431,1206,1346,919,1373
g22170,P25867,UBCD1_DROME,UBCD1_DROME,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),eff UbcD1 CG7425,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,120,92,237,251,203,178,183,198,57,18,34,61,83,6,65,36,29,39,29,12,6,10,150,75,71,83,40,24
g23479,P46379,BAG6_HUMAN,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381,317,308,481,326,403,281,287,423,457,666,180,502,411,364,245,1210,463,205,275,406,496,434,194,138,198,177,124,130
g23478,P46379,BAG6_HUMAN,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0036503; GO:0036506; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043161; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0060090; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071816; GO:0071818; GO:0140677; GO:1904294; GO:1990381,1268,1561,1950,1153,2049,1549,1671,1951,2420,3298,952,2448,2037,2169,1183,5794,2700,1074,1432,2661,2802,1851,1439,839,898,910,755,744
g2493,Q9PTW9,PSA7_CARAU,PSA7_CARAU,Proteasome subunit alpha type-7 (Proteasome subunit alpha 4),psma7,proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0010498; GO:0019773,2752,1586,1586,1302,2095,1742,1273,1750,2045,2146,1191,2874,2521,939,3482,1673,1828,786,1170,1031,599,748,1166,779,785,633,464,507
g9303,Q9UMX0,UBQL1_HUMAN,UBQL1_HUMAN,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),UBQLN1 DA41 PLIC1,aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0036503; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1904294,2727,4466,4750,3453,5104,4244,4322,4686,3945,5123,3411,5811,5136,1888,2801,6093,4054,2700,2690,3377,2527,2534,2663,1976,2131,1928,1271,1805
g6282,Q9Z2A5,ATE1_MOUSE,ATE1_MOUSE,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),Ate1,proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0010498,421,796,874,802,754,846,709,873,989,758,1268,884,1166,427,1609,1028,593,722,428,571,379,449,621,447,392,461,427,406
g6283,O95260,ATE1_HUMAN,ATE1_HUMAN,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),ATE1,proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0006979; GO:0010498; GO:0016598,970,1295,1110,1097,1315,1282,1144,1257,1164,1164,1476,1157,1708,493,2315,1222,789,1032,667,726,458,556,833,582,605,640,354,445
g9683,Q6ZT12,UBR3_HUMAN,UBR3_HUMAN,E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650),UBR3 KIAA2024 ZNF650,embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878,1115,1013,1526,1071,1032,1135,1488,1739,229,130,237,1105,457,18,251,161,127,232,221,164,60,59,1165,879,438,992,868,656
g16612,Q5ZHY5,CHIP_CHICK,CHIP_CHICK,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),STUB1 RCJMB04_32b21,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006281; GO:0006511; GO:0006515; GO:0030018; GO:0034450; GO:0042803; GO:0043161; GO:0045862; GO:0051087; GO:0061630; GO:0071218,351,377,417,328,325,416,387,444,172,53,161,294,107,13,273,58,35,95,81,41,30,22,199,223,124,229,267,281
g12805,Q8TDB6,DTX3L_HUMAN,DTX3L_HUMAN,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),DTX3L BBAP,defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008333; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646,89,378,745,519,491,257,334,715,300,225,172,397,372,618,190,1914,528,841,558,263,576,448,549,177,131,398,267,183
g19157,Q8CJB9,BRE1B_RAT,BRE1B_RAT,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B) (Syntaxin-1-interacting RING finger protein) (Protein staring),Rnf40 Bre1b,chromatin organization [GO:0006325]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000151; GO:0003730; GO:0004842; GO:0005634; GO:0006325; GO:0006511; GO:0016567; GO:0017075; GO:0031624; GO:0031625; GO:0032991; GO:0033503; GO:0042803; GO:0043434; GO:0045944; GO:0046872; GO:0061630; GO:1901800; GO:1902916,1700,2972,2495,1840,1520,1668,2822,2787,2773,3693,1601,2598,3025,1657,2062,3165,1795,2274,1202,839,1893,2061,1222,786,634,1367,1208,954
g18018,Q5U2S1,NFIP1_RAT,NFIP1_RAT,NEDD4 family-interacting protein 1,Ndfip1 N4wbp5,"CD4-positive, alpha-beta T cell proliferation [GO:0035739]; intracellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; protein catabolic process [GO:0030163]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]",GO:0000139; GO:0002761; GO:0002829; GO:0005576; GO:0005783; GO:0005794; GO:0005938; GO:0006511; GO:0006879; GO:0007034; GO:0010008; GO:0010629; GO:0030001; GO:0030163; GO:0030425; GO:0031398; GO:0032713; GO:0035739; GO:0045202; GO:0045619; GO:0045732; GO:0048294; GO:0048302; GO:0048471; GO:0050699; GO:0050728; GO:0051224; GO:2000562,770,1338,1748,1287,1688,1614,1504,1350,1432,1682,1409,2023,1762,820,884,1804,1089,1063,751,815,712,868,892,575,639,587,852,567